BridgeMD
New treatment option for HPV (Human Papillomavirus)-Associated
Official title Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
ClinicalTrials.gov ID: NCT07698886
What this study is testing
What is Geniwa gel?
Geniwa gel is an investigational medicine, given as an once-weekly treatment applied to the skin, being studied as a potential treatment for hpv (human papillomavirus)-associated.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older.
- Able to read and understand the Patient Information Sheet and the Informed Consent form.
- Acceptance in the participation of the essay and signature of the Informed Consent form.
- Diagnosis of genital and anal warts with clear clinical manifestations.
- Have undergone at least 3 laser treatments and have experienced recurrence in any location.
You likely can't join if
- Concomitant sexually transmitted infections such as gonorrhea, syphilis, genital herpes, etc., that have not been cured.
- Ulceration or suspected malignant transformation of the lesions.
- Local infections.
- Pregnant women.
- Allergies to any component of alpha-lactalbumin-oleic acid gel.
See the full eligibility criteria
- 18 years of age or older.
- Able to read and understand the Patient Information Sheet and the Informed Consent form.
- Acceptance in the participation of the essay and signature of the Informed Consent form.
- Diagnosis of genital and anal warts with clear clinical manifestations.
- Have undergone at least 3 laser treatments and have experienced recurrence in any location.
- At least four or more lesions, or a lesion area of at least 0.5 cm2.
- Concomitant sexually transmitted infections such as gonorrhea, syphilis, genital herpes, etc., that have not been cured.
- Ulceration or suspected malignant transformation of the lesions.
- Local infections.
- Pregnant women.
- Allergies to any component of alpha-lactalbumin-oleic acid gel.
The study team makes the final eligibility decision.
Where it's taking place
- Hanoi, None (International), Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hanoi, None (International), Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.